Microdosing semaglutide uses doses below the standard starting strength. See how a semaglutide microdosing chart works, plus risks and what to ask your doctor.
Microdosing semaglutide means using doses well below the standard FDA-approved starting amount of 0.25 mg per week, usually by drawing a smaller volume from a vial or counting fewer clicks on a pen. No FDA-approved microdosing schedule exists, and no large clinical trial has tested whether these lower doses deliver the same weight loss as the labeled titration. Most people try it hoping to avoid nausea, but the trade-off is often weaker appetite suppression.
How Microdosing Semaglutide Works
Semaglutide is a GLP-1 receptor agonist. It slows stomach emptying and signals the brain to feel full, which is why appetite drops and portions shrink for many users.
Standard schedules raise the dose every four weeks because the body adapts and higher doses generally produce more weight loss. Microdosing holds the dose low, sometimes for months, instead of escalating on that timeline.
People microdose in three main ways:
- Splitting one weekly injection into two smaller shots.
- Drawing a reduced volume from a compounded vial with an insulin syringe.
- Counting fewer clicks on a multi-dose pen, such as 10 clicks instead of a full dose.
Every one of those methods adds dosing-error risk. Pens are not engineered for fractional dosing, and compounded vials vary widely in concentration.
Microdosing Semaglutide Chart vs. Standard Titration
The table below is an example only. It is not a prescription and it is not the manufacturer's schedule.
| Weeks | Standard titration (Wegovy) | Example microdosing approach | What typically changes |
|---|---|---|---|
| 1-4 | 0.25 mg weekly | 0.05-0.10 mg weekly | Fewer GI symptoms, minimal appetite effect |
| 5-8 | 0.5 mg weekly | 0.10-0.20 mg weekly | Mild appetite suppression may appear |
| 9-12 | 1.0 mg weekly | 0.20-0.30 mg weekly | Full therapeutic effect unlikely |
| 13-16 | 1.7 mg weekly | 0.30-0.50 mg weekly | Approaches a low maintenance level |
| 17+ | 2.4 mg weekly (target) | 0.50 mg or less, held steady | Weight loss is usually slower |
The labeled maintenance dose for Wegovy is 2.4 mg weekly. Ozempic, approved for type 2 diabetes, uses a similar but separate schedule and tops out at 2 mg weekly.
Does Microdosing Reduce Side Effects?
Nausea, vomiting, diarrhea, and constipation are the most common complaints with semaglutide. A frequent question, does everyone have side effects from semaglutide, has a simple answer: no. In clinical trials, a large share of participants reported no significant GI symptoms at all.
Lower doses usually cause fewer stomach issues, which is exactly why the standard schedule starts low and climbs gradually. Microdosing simply stretches that low phase out, sometimes indefinitely.
Two things to keep in mind:
- Side effects can still occur at very small doses, especially in people who are sensitive to GLP-1 drugs.
- Tolerating a microdose does not guarantee you will tolerate a full dose later.
Why the Dose Goes Up, and What Microdosing Gives Up
This is why increase dose of semaglutide for weight loss is tied directly to dose-response data: in the STEP trials, 2.4 mg produced substantially more weight loss than 1.0 mg, and both beat placebo by a wide margin. Appetite suppression at 0.1 mg is often barely noticeable.
Staying low may make sense for someone who cannot tolerate standard doses at all. It rarely matches the results seen in the trials that got the drug approved.
Microdosing semaglutide is not an FDA-approved dosing strategy, and it should not be treated as a gentler version of the real thing.
Practical Risks of Microdosing Semaglutide
Anyone wondering where to buy semaglutide should know that compounded semaglutide is not FDA-approved, and regulators have warned repeatedly about unverified online sellers. Semaglutide ingredients in compounded products may include different salt forms, such as semaglutide sodium or acetate, which are not interchangeable with brand-name medication.
Other practical problems include:
- Math errors when converting milligrams to units on a syringe.
- Unknown potency in vials that have not been independently tested.
- Loss of the manufacturer's safety monitoring and support program.
Oral semaglutide is dosed daily, not weekly. The semaglutide tablet dose for weight loss follows a totally different scale, so a weekly microdosing chart does not translate to pills.
Safety, Alcohol, and Talking to a Clinician
Semaglutide and alcohol can both upset the stomach, and pairing them may worsen nausea and dehydration. Alcohol also adds empty calories that work against any weight-loss goal.
Semaglutide is not a cure for obesity. It is a long-term medication that works best alongside diet, movement, and sleep, and it usually needs to be continued to keep weight off.
Before changing your dose in any way, talk with a licensed healthcare professional who can review your history, your current prescription, and any other medications you take.
Bottom Line
Microdosing semaglutide is an off-label experiment, not a proven protocol. There is no clinical trial data confirming that microdoses produce meaningful weight loss, and compounded versions carry added uncertainty about purity and potency.
If standard doses cause intolerable side effects, the safer path is a supervised dose adjustment or a different medication rather than a homemade schedule. A clinician can help you decide whether staying low, switching drugs, or pausing treatment makes the most sense for your health.
Frequently Asked Questions
What is a microdosing semaglutide chart?
A microdosing semaglutide chart is an informal table that maps out doses far below the FDA-approved titration, often starting around 0.05 to 0.10 mg per week instead of 0.25 mg. These charts are created by users and clinics, not by drug manufacturers, and they are not backed by clinical trials.
Can you still lose weight while microdosing semaglutide?
Some people report modest weight loss on very low doses, but there is no trial evidence that microdosing matches the results of the approved 2.4 mg maintenance dose. Weight loss from semaglutide generally scales with dose, so microdosing often means slower or smaller results.
Is microdosing semaglutide safer than the standard dose?
Microdosing may cause fewer stomach-related side effects, but it is not automatically safer. Compounded products are not FDA-approved, dosing errors are common, and skipping the standard titration means giving up the safety monitoring that comes with brand-name prescriptions.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.